Loading provider…
Loading provider…
Dermatology Physician in New York, NY
NPI: 1063512341Primary Practice Location
HOSPITAL FOR SPECIAL SURGERY
535 E 70th St, New York, NY
HQ Phone
Get M.D. David's Phone Numberphone_androidMobile
Get M.D. David's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License
CA State Medical License
1971
NY State Medical License
1970 - 2026
OH State Medical License
1977 - 2021

American Board of Dermatology
Dermatology
Rockefeller University Hospital
Fellowship • 1974 - 1977
1974 - 1977
NYU Grossman School of Medicine
med.nyu.edu
Residency • Dermatology
1970 - 1973
University of Iowa Hospitals and Clinics
Internship • Transitional Year
1967 - 1968
Georgetown University
BA • Classics
1959 - 1963
UVA School of Medicine
med.virginia.edu
Medical School
Until 1967
Cyclooxygenase-2 inhibitor nimesulide blocks ultraviolet B-induced photocarcinogenesis in SKH-1 hairless mice.
Authors: Xiuwei Tang, Arianna L. Kim, Levy Kopelovich, David R. Bickers, Mohammad Athar
Publication Date: 2008-03
Fifty Years of Collaboration between the SID and ESDR: Two Societies and One Journal.
Authors: Richard Gallo
Journal: J Invest Dermatol
Authors: Das, M, Khan, W A, Asokan, P, Bickers, D R, Mukhtar, H
Journal: Cancer Res
Lead Sponsor: Sol-Gel Technologies, Ltd.
Intervention / Treatment: DRUG: Patidegib Topical Gel, 2%, DRUG: Patidegib Topical Gel, Vehicle
Lead Sponsor: UCSF Benioff Children's Hospital Oakland
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: placebo, DRUG: tazarotene
Lead Sponsor: UCSF Benioff Children's Hospital Oakland
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: tazarotene